US warns Abraxis BioScience about plant problems

WASHINGTON, Feb 15 (Reuters) - U.S. regulators have warned Abraxis BioScience Inc. ABBI.O about manufacturing problems at an Illinois plant, according to a letter released on Thursday.

The Food and Drug Administration letter to Abraxis, dated Dec. 18, 2006, said the issues "need more timely and comprehensive corrections than the actions you have proposed or taken."

((Reporting by Lisa Richwine, editing by Gunna Dickson; Reuters Messaging: lisa.richwine.reuters.com@reuters.net; +1 202 310-5691)) Keywords: ABRAXIS WARNING/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWAT007000